Navigation Links
Peregrine Pharmaceuticals to Report Third Quarter FY 2009 Financial Results
Date:3/5/2009

TUSTIN, Calif., March 5 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that it will release its financial results for the third quarter of fiscal year 2009 on March 12, 2009 at 7:00 a.m. EDT and will host a conference call and webcast to discuss the results at 11:30 a.m. EDT on the same day.

Peregrine's senior management will discuss financial results for the third quarter ended January 31, 2009 and will review recent operating highlights. A question-and-answer session will follow management's discussion. All interested parties are encouraged to listen to the live conference call or the archived webcast.

The conference call and webcast will begin at 11:30 a.m. EDT/ 8:30 a.m. PDT. To listen to a live broadcast of the call over the Internet or to review the archived webcast, please visit: http://www.peregrineinc.com. The webcast will be archived on Peregrine's website for 30 days.

To listen to the conference call via telephone, please call the following number approximately 10 minutes prior to the scheduled start time and request to join the Peregrine Pharmaceuticals call: (800) 860-2442. A telephonic replay of the conference call will be available starting approximately one hour after the conclusion of the call through March 19, 2009 by calling (877) 344-7529, passcode 382933#.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manuf
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study
2. Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2009
3. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
4. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
5. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
6. Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
7. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
8. Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2008 Financial Results and to Host Conference Call and Webcast on Thursday, March 12, 2009
9. Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer
10. Frost & Sullivan Lauds OVATION Pharmaceuticals for Its Business Model and Ability to Sustain Growth
11. NovaBay Pharmaceuticals Announces New Preclinical Data to be Presented at the American Academy of Dermatology (AAD) 67th Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... that cancer cells have a much different and ... at The University of Texas at Dallas have found ... to combat lung cancer. , In an article published ... , UT Dallas researchers compared the metabolic characteristics of ... from the same patient. , They found that ...
(Date:6/18/2013)... June 18, 2013 The July 2013 issue ... Guide to Getting Beach Ready,” offers a list of home ... their best in a bathing suit this summer. The list ... firming , smoothing cellulite , and more. (go to ... Medical Director of Epione Beverly Hills, “though I would say ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 A new ... storm. The burgeoning aquaculture industry is redefining the way ... of the most acclaimed personal culinary chefs on the ... on benefits of sustainable seafood and the promising industry ... abundance these days. Many consumers strive to fully partake ...
(Date:6/18/2013)... By studying one of the most successful ... of successful strategies in his article What We Can ... Study. , The inspirational brand Gollan refers to is ... an impressive 62 million followers (and rising). , The ... Facebook Pages earlier this year. The Facebook data tracking publication ...
(Date:6/18/2013)... President Obama officially declared June as Lesbian, ... However, despite advances in civil rights, sexual ... for suicide than their heterosexual peers, according ... University of Missouri psychology graduate student recently ... sexual minority youth, which could help improve ...
Breaking Medicine News(10 mins):Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:Skin Care – Getting Your Body Beach Ready 2Health News:New $119 Million Industry Swimming Up the East Coast 2Health News:Casey Gollan Shows What We Can Learn From One of the Best Facebook Pages There Is 2Health News:Casey Gollan Shows What We Can Learn From One of the Best Facebook Pages There Is 3Health News:Sexual minority youth need specialized treatment from therapists 2
... - Reiterates 2008 Revenue Guidance of $50 Million, ... DIET ), leveraging the power of the Internet to ... announced,results for the quarter and twelve months ended December ... fourth quarter of 2007 were,$6.9 million, compared to $9.5 ...
... cheap drugs are less effective, researchers find , , TUESDAY, ... medication is expensive, they tend to report more benefit than ... finds. , In fact, 85 percent of people given ... reduction in pain, compared with 61 percent of those given ...
... Governor Edward G.,Rendell,s health care team today ... Governor,s Cover All Pennsylvanians continues to grow and, ... and tobacco products, there are,funds to pay for ... the team told the House of Representatives Appropriations,Committee ...
... Strategies and Lessons Learned in Building a Unified, ... What is essential to,developing a successful, integrated cardiovascular ... help you develop a,project strategy that sets proper ... same page? What tools will help you unify ...
... finds little difference in effectiveness of 5 drugs currently ... no proof that any one of the five drugs ... better than the others, says an American College of ... committee that just issued a new guideline on drug ...
... prevalence of adverse drug reactions in the treatment of ... than their male counterparts to be treated with statins, ... researchers at Rush University Medical Center. The study is ... Medicine. , Developments in disease recognition and novel treatment ...
Cached Medicine News:Health News:eDiets.com(R) Announces Q4 and Year End 2007 Results 2Health News:eDiets.com(R) Announces Q4 and Year End 2007 Results 3Health News:eDiets.com(R) Announces Q4 and Year End 2007 Results 4Health News:eDiets.com(R) Announces Q4 and Year End 2007 Results 5Health News:eDiets.com(R) Announces Q4 and Year End 2007 Results 6Health News:eDiets.com(R) Announces Q4 and Year End 2007 Results 7Health News:Price Plays Part in Perceived Power of Medication 2Health News:Price Plays Part in Perceived Power of Medication 3Health News:Governor Rendell's Health Care Reform Cabinet Says Providing Access to Health Care for Pennsylvania's Uninsured is Within Reach 2Health News:Governor Rendell's Health Care Reform Cabinet Says Providing Access to Health Care for Pennsylvania's Uninsured is Within Reach 3Health News:Governor Rendell's Health Care Reform Cabinet Says Providing Access to Health Care for Pennsylvania's Uninsured is Within Reach 4Health News:Achieving CVIS Goals Webinar 2Health News:Groups Issue New Dementia Drug Guidelines 2Health News:Women are treated less frequently than men with statins, aspirin and beta-blockers 2
(Date:6/17/2013)... Prime Therapeutics, in collaboration with public relations agency, ... the Silver Anvil for its internal communication campaign "Millions of ... at the Public Relations Society of America (PRSA) 2013 ... AXA Equitable Center in New York ... been presented annually since 1946, is the oldest and one ...
(Date:6/17/2013)... June 17, 2013 /PRNewswire-iReach/ -- Weiler Labeling Systems, ... X-4S pressure sensitive labeling head. The X-4S is ... performance requirements that serialization demands. ... uniquely qualified to work with pharmaceutical and medical ... and track and trace implementation strategies. Designed for ...
(Date:6/17/2013)... WORCESTER, Mass. and TORONTO ... www.generex.com ) (OTCBB:GNBT) today announced that it entered into ... June 17, 2013.  The investors have agreed to purchase ... of the Company,s newly designated non-voting Series E 9% ... purchase up to an aggregate of 100% of the ...
Breaking Medicine Technology:Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America 2Weiler Labeling Introduces Serialization-Capable X-4S Labeling Head 2Generex Announces $1,225,000 Capital Investment 2Generex Announces $1,225,000 Capital Investment 3Generex Announces $1,225,000 Capital Investment 4Generex Announces $1,225,000 Capital Investment 5
... percutaneous placement of a pigtail ... for nephrostomy drainage in neonatal ... in peel-open packages. Intended for ... is advised; catheter must not ...
... BioPlex 2200 system is a fully ... can deliver up to 2200 results ... include a panel of assays targeting ... are in the areas of serology, ...
... and a FAM-labeled probe targeting the glycoprotein D ... primers and an Alexa 532-labeled probe designed to ... 2. This ASR requires an instrument that can ... like the Cepheid SmartCycler System. The Cepheid Analyte ...
... The HSV Non-Typing ASR contains primers and ... a 92 bp region of the HSV Type ... requires an instrument that can detect a FAM ... The Cepheid Analyte Specific Reagent* (ASR) program is ...
Medicine Products: